Meeder Asset Management Inc Sc Pharmaceuticals Inc. Transaction History

Meeder Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 11, 2020	SELL	$7.01 - $10.96 $5,110 - $7,989	-729 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$5.4 - $10.45 $1,949 - $3,772	-361 Reduced 33.12%	729 $6,000
Q3 2019 Oct 17, 2019	BUY	$3.24 - $7.35 $398 - $904	123 Added 12.72%	1,090 $6,000
Q2 2019 Aug 05, 2019	BUY	$2.48 - $3.76 $1,396 - $2,116	563 Added 139.36%	967 $3,000
Q1 2019 Apr 16, 2019	BUY	$2.84 - $4.18 $366 - $539	129 Added 46.91%	404 $1,000
Q4 2018 Jan 17, 2019	BUY	$3.76 - $5.61 $1,034 - $1,542	275 New	275 $1,000

37.1M

110K

12.1K

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $89.1M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.